RK33 (diimidazole [4,5-d:40,50-f]-[1,3]diazepine), a synthetic DDX3-specific inhibitor, induced tumor regression in lung cancer mouse models [49], suggesting that this protein might be crucial for cancer treatment. Here, DDX3X is linked to lung carcinoma.